ResearchMoz

Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators

GBI Research
Published Date » 2011-09-15
No. Of Pages » 120

GBI Researchs report, Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators provides key data, information and analysis on the global drug delivery device market. The report provides the market landscape, competitive landscape and market trend information on four drug delivery device market categories, namely central venous catheters, infusion systems, metered dose inhaler devices and needle-free injections. 

The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. The report also reviews the details of important merger and acquisition deals that have taken place in the drug delivery device market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Market size and company share data for four drug delivery device market categories - central venous catheters, infusion systems, metered dose inhaler devices and needle-free injections.
  • Annualized market revenues data from 2003 to 2010 and the forecast to 2017. Company share data for 2010 has been given for all categories.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the drug delivery device market.
  • The report also covers information on the leading market players, the competitive landscape and leading technology.
  • Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Hospira, Inc, CareFusion Corporation, Baxter International Inc, Teleflex Incorporated and INJEX - Equidyne Systems.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the drug delivery device market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
  • What is the next big thing in the drug delivery device market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global drug delivery device market and the factors shaping it.
Table of Contents

1 Table of Contents

1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 10
2.1 GBI Research Guidance 10

3 Drug Delivery Devices - Market Characterization 11
3.1 Global Drug Delivery Device Market, Revenue ($m), 2003-2010 11
3.2 Global Drug Delivery Device Market, Revenue Forecast ($m), 2010-2017 12
3.3 Global Drug Delivery Device Market, Key Technology Trends 13
3.3.1 Future Applications of Nano-Enabled Drug Delivery 13
3.3.2 Increased Application of Microneedle Enhanced Drug Delivery to Include Skin Cancer 15
3.3.3 Smart Infusion Pumps Equipped with Computerized Prescriber Order Entry (CPOE), and Bar-Coded Medication Administration (BCMA) Prevent Medication Errors 15
3.3.4 Specialized Drug Delivery Systems to Deliver Biologics and Biotech Compounds will Augment Market Growth 15
3.3.5 Transcutaneous Immunization (TCI) - Needle-Free Drug Delivery Technology used as Immunostimulant 16
3.4 Global Drug Delivery Device Market, Market Dynamics 17
3.4.1 Market Drivers 17
3.4.2 Market Restraints 20
3.5 Global Drug Delivery Device Market, Key Company Share (%), 2010 22

4 Global Drug Delivery Device Market - Category Analysis and Forecasts 23
4.1 Drug Delivery Devices 23
4.2 Central Venous Catheters 23
4.2.1 Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
4.2.2 Central Venous Catheter Market, Global, Revenue Forecast ($m), 2010-2017 25
4.2.3 Central Venous Catheters - Market Dynamics 26
4.2.4 Market Drivers 26
4.2.5 Market Restraints 27
4.2.6 Central Venous Catheter Market, Global, Company Share (%), 2010 29
4.3 Infusion Systems 30
4.3.1 Infusion System Market, Global, Revenue ($m), 2003-2010 30
4.3.2 Infusion System Market, Global, Revenue Forecast ($m), 2010-2017 31
4.3.3 Infusion Systems - Market Dynamics 32
4.3.4 Market Drivers 32
4.3.5 Market Restraints 34
4.3.6 Infusion System Market, Global, Company Share (%), 2010 37
4.4 Metered Dose Inhaler Devices 38
4.4.1 Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
4.4.2 Metered Dose Inhaler Device Market, Global, Revenue Forecasts ($m), 2010-2017 39
4.4.3 Metered Dose Inhaler Devices - Market Dynamics 40
4.4.4 Market Drivers 40
4.4.5 Market Restraints 42
4.4.6 Metered Dose Inhaler Device Market, Global, Company Share (%), 2010 43
4.5 Needle-Free Injections 44
4.5.1 Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 44
4.5.2 Needle-Free Injection Market, Global, Revenue Forecasts ($m), 2010-2017 46
4.5.3 Needle-Free Injections - Market Dynamics 47
4.5.4 Market Drivers 47
4.5.5 Market Restraints 49
4.5.6 Needle-Free Injection Market, Global, Company Share (%), 2010 50

5 Global Drug Delivery Device Market - Country Analysis and Forecasts 51
5.1 Drug Delivery Device Market - Cross-Country Analysis 51
5.2 Revenue Forecasts, By Country, 2003-2017 52
5.2.1 Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
5.2.2 Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
5.2.3 Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
5.2.4 Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
5.2.5 Drug Delivery Device Market, UK, Revenue ($m), 2003-2010 56
5.2.6 Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
5.2.7 Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
5.2.8 Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
5.2.9 Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
5.2.10 Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
5.2.11 Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
5.2.12 Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
5.2.13 Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
5.2.14 Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
5.2.15 Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
5.2.16 Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
5.2.17 Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
5.2.18 Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
5.2.19 Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
5.2.20 Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
5.2.21 Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
5.2.22 Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
5.2.23 Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
5.2.24 Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75

6 Global Drug Delivery Device Market - Competitive Assessment 76
6.1 Drug Delivery Devices, Market Opportunities and Risk Evaluation 76
6.2 GlaxoSmithKline plc 78
6.2.1 Business Overview 78
6.2.2 Key Products 78
6.3 Boehringer Ingelheim GmbH 79
6.3.1 Business Overview 79
6.3.2 Key Products 80
6.4 AstraZeneca plc 81
6.4.1 Business Overview 81
6.4.2 Key Products 82
6.5 Hospira, Inc. 83
6.5.1 Business Overview 83
6.5.2 Key Products 84
6.6 CareFusion Corporation 85
6.6.1 Business Overview 85
6.6.2 Key Products 86
6.7 Baxter International Inc. 87
6.7.1 Business Overview 87
6.7.2 Key Products 88
6.8 Teleflex Incorporated 88
6.8.1 Business Overview 88
6.8.2 Key Products 89
6.9 INJEX - Equidyne Systems 90
6.9.1 Business Overview 90
6.9.2 Key Products 90

7 Drug Delivery Device Market - Pipeline Product Analysis 91
7.1 Drug Delivery Devices - Pipeline Product Summary 91
7.2 Injectable Drug Delivery 92
7.2.1 Injectable Drug Delivery - List of Pipeline Products 92
7.2.2 Injectable Drug Delivery - Profiles of Key Pipeline Products 94
7.3 Metered Dose Inhalers 95
7.3.1 Metered Dose Inhalers - List of Pipeline Products 95
7.3.2 Metered Dose Inhalers - Profiles of Key Pipeline Products 95
7.4 Infusion Systems 96
7.4.1 Infusion Systems - List of Pipeline Products 96
7.4.2 Infusion Systems - Profiles of Key Pipeline Products 97
7.5 Needle-Free Injections 98
7.5.1 Needle-Free Injections - List of Pipeline Products 98
7.5.2 Needle-Free Injections - Profiles of Pipeline Products 98
7.6 Peripherally Inserted Central Catheter 99
7.6.1 Peripherally Inserted Central Catheter - List of Pipeline Products 99
7.6.2 Peripherally Inserted Central Catheter - Profiles of Key Pipeline Products 99
7.7 Transdermal Drug Delivery Devices 100
7.7.1 Transdermal Drug Delivery Devices - List of Pipeline Products 100
7.7.2 Transdermal Drug Delivery Devices - Profiles of Key Pipeline Products 102
7.8 Transmucosal Drug Delivery Devices 103
7.8.1 Transmucosal Drug Delivery Devices - List of Pipeline Products 103
7.8.2 Transmucosal Drug Delivery - Profiles of Key Pipeline Products 104
7.9 Inhalable Drug Delivery Devices 105
7.9.1 Inhalable Drug Delivery Devices - List of Pipeline Products 105
7.9.2 Inhalable Drug Delivery - Profiles of Key Pipeline Products 106
7.10 Niche Technologies 107
7.10.1 Niche Technologies - List of Pipeline Products 107
7.10.2 Niche Technologies - Profiles of Key Pipeline Products 108

8 Global Drug Delivery Device Market - Consolidation Landscape 109
8.1 Deals by Count, 2007-2010 109
8.2 Key Deals in 2007-2010 112
8.2.1 Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 112
8.2.2 Kimberly-Clark Completes Acquisition of I-Flow 113
8.2.3 Surmodics Acquires Brookwood Pharmaceuticals 114

9 Appendix 116
9.1 Definitions 116
9.1.1 Drug Delivery Devices 116
9.2 Acronyms 117
9.3 Research Methodology 118
9.3.1 Secondary Research 118
9.3.2 Primary Research 118
9.3.3 Models 119
9.3.4 Forecasts 119
9.3.5 Expert Panel 119
9.4 Contact Us 119
9.5 Disclaimer 120
9.6 Sources 120

List of Tables


Table 1: Drug Delivery Device Market, Global, Revenue ($m), 2003-2010 11
Table 2: Drug Delivery Device Market, Global, Revenue ($m), 2010-2017 12
Table 3: Drug Delivery Device Market, Global, Key Company Revenues ($m), 2010 22
Table 4: Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
Table 5: Central Venous Catheter Market, Global, Revenue ($m), 2010-2017 25
Table 6: Central Venous Catheter Market, Global, Key Company Revenues ($m), 2010 29
Table 7: Infusion System Market, Global, Revenue ($m), 2003-2010 30
Table 8: Infusion System Market, Global, Revenue ($m), 2010-2017 31
Table 9: Infusion System Market, Global, Key Company Revenues ($m), 2010 37
Table 10: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
Table 11: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2010-2017 39
Table 12: Metered Dose Inhaler Device Market, Global, Key Company Revenues ($m), 2010 43
Table 13: Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 45
Table 14: Needle-Free Injection Market, Global, Revenue ($m), 2010-2017 46
Table 15: Needle-Free Injection Market, Global, Key Company Revenues ($m), 2010 50
Table 16: Drug Delivery Device Market, Global, Cross-Country Analysis, CAGR (%), 2003-2017 51
Table 17: Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
Table 18: Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
Table 19: Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
Table 20: Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
Table 21: Drug Delivery Device Market, the UK, Revenue ($m), 2003-2010 56
Table 22: Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
Table 23: Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
Table 24: Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
Table 25: Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
Table 26: Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
Table 27: Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
Table 28: Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
Table 29: Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
Table 30: Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
Table 31: Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
Table 32: Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
Table 33: Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
Table 34: Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
Table 35: Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
Table 36: Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
Table 37: Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
Table 38: Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
Table 39: Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
Table 40: Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75
Table 41: Drug Delivery Systems, Global, Pipeline Products Summary, 2010 91
Table 42: Injectable Drug Delivery - List of Pipeline Products-1, 2011 92
Table 43: Injectable Drug Delivery - List of Pipeline Products-2, 2011 93
Table 44: Metered Dose Inhalers: List of Pipeline Products, 2010 95
Table 45: Infusion Systems - List of Pipeline Products, 2011 96
Table 46: Needle-Free Injections: List of Pipeline Products, 2010 98
Table 47: Peripherally Inserted Central Catheter - List of Pipeline Products, 2010 99
Table 48: Transdermal Drug Delivery Devices - List of Pipeline Products-I, 2011 100
Table 49: Transdermal Drug Delivery Devices - List of Pipeline Products-II, 2011 101
Table 50: Transmucosal Drug Delivery Devices - List of Pipeline Products, 2011 103
Table 51: Inhalable Drug Delivery Devices - List of Pipeline Products, 2011 105
Table 52: Niche Technologies - List of Pipeline Products, 2011 107
Table 53: Drug Delivery Device Market, Mergers & Acquisitions, by Number of Deals, Global, 2007-2010 109
Table 54: Drug Delivery Device Market, Mergers & Acquisitions, by Volume-1, Global, 2007-2010 110
Table 55: Drug Delivery Device Market, Mergers & Acquisitions, by Volume-2, Global, 2007-2010 111

List of Figures


Figure 1: Drug Delivery Device Market, Global, Revenue ($m), 2003-2010 11
Figure 2: Drug Delivery Device Market, Global, Revenue ($m), 2010-2017 12
Figure 3: Nanotechnology in Drug Delivery, Future Applications of Nanotechnology in Medical Devices, 2011 13
Figure 4: Drug Delivery Devices, Market Dynamics 17
Figure 5: Advantages of New Drug Delivery Technology, 2011 19
Figure 6: Drug Delivery Device Market, Global, Company Share (%), 2010 22
Figure 7: Drug Delivery Devices, Market Categorization and Segmentation 23
Figure 8: Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
Figure 9: Central Venous Catheter Market, Global, Revenue ($m), 2010-2017 25
Figure 10: Central Venous Catheters, Market Dynamics 26
Figure 11: Central Venous Catheter Market, Global, Company Share (%), 2010 29
Figure 12: Infusion System Market, Global, Revenue ($m), 2003-2010 30
Figure 13: Infusion System Market, Global, Revenue ($m), 2010-2017 31
Figure 14: Infusion Systems, Market Dynamics 32
Figure 15: Infusion System Market, Global, Company Share (%), 2010 37
Figure 16: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
Figure 17: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2010-2017 39
Figure 18: Metered Dose Inhaler Devices, Market Dynamics 40
Figure 19: Metered Dose Inhaler Device Market, Global, Company Share (%), 2010 43
Figure 20: Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 44
Figure 21: Needle-Free Injection Market, Global, Revenue ($m), 2010-2017 46
Figure 22: Needle-Free Injections, Market Dynamics 47
Figure 23: Needle-Free Injection Market, Global, Company Share (%), 2010 50
Figure 24: Drug Delivery Device Market, Cross-Country Analysis, Global, CAGR (%), 2002-2016 51
Figure 25: Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
Figure 26: Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
Figure 27: Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
Figure 28: Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
Figure 29: Drug Delivery Device Market, UK, Revenue ($m), 2003-2010 56
Figure 30: Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
Figure 31: Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
Figure 32: Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
Figure 33: Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
Figure 34: Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
Figure 35: Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
Figure 36: Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
Figure 37: Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
Figure 38: Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
Figure 39: Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
Figure 40: Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
Figure 41: Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
Figure 42: Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
Figure 43: Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
Figure 44: Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
Figure 45: Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
Figure 46: Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
Figure 47: Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
Figure 48: Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75
Figure 49: Drug Delivery Devices, Market Opportunities and Risk Evaluation, Global, by Segment 76
Figure 50: Drug Delivery Devices, Competitive Assessment, 2010 77
Figure 51: GlaxoSmithKline plc, SWOT Analysis, Drug Delivery Devices, Global, 2010 78
Figure 52: Boehringer Ingelheim GmbH, SWOT Analysis, Drug Delivery Devices, Global, 2010 79
Figure 53: AstraZeneca plc, SWOT Analysis, Drug Delivery Devices, Global, 2010 81
Figure 54: Hospira, Inc., SWOT Analysis, Drug Delivery Devices, Global, 2010 83
Figure 55: CareFusion, SWOT Analysis, Drug Delivery Devices, Global, 2010 85
Figure 56: Baxter International Inc, SWOT Analysis, Drug Delivery Devices, Global, 2010 87
Figure 57: Teleflex Incorporated, SWOT Analysis, Drug Delivery Devices, Global, 2010 89
Figure 58: INJEX Equidyne Systems, SWOT Analysis, Drug Delivery Devices, Global, 2010 90
Figure 59: Drug Delivery Systems, Global, Pipeline Products Summary, 2010 91
Figure 60: Drug Delivery Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 109

Upcoming Reports:

Poland: ice cream market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the ice cream market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the ice cream market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Poland: walnuts market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the walnuts market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the walnuts market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Greece: apple juice market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the apple juice market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the apple juice market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...